Stay updated on Mesenchymal Stromal Cells vs Best Available Therapy in GVHD: Clinical Trial
Sign up to get notified when there's something new on the Mesenchymal Stromal Cells vs Best Available Therapy in GVHD: Clinical Trial page.

Latest updates to the Mesenchymal Stromal Cells vs Best Available Therapy in GVHD: Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe site footer now identifies the ClinicalTrials.gov release as v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check16 days agoChange DetectedA banner announces that federal agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence” under Executive Order 14434, with a link to updates and FAQs.SummaryDifference0.7%

- Check23 days agoChange DetectedThe footer site revision label changes from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check30 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check51 days agoChange DetectedThe Record History section adds a new version entry (Revision: v3.7.0) and normalizes the contact information label by changing 'Find Contact Information' to 'Find contact information', reflecting a small UI/text update.SummaryDifference0.2%

- Check72 days agoChange DetectedA new revision entry (v3.6.6) has been added to the record history, updating the study's version history and superseding the previous revision (v3.6.5).SummaryDifference0.1%

Stay in the know with updates to Mesenchymal Stromal Cells vs Best Available Therapy in GVHD: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Mesenchymal Stromal Cells vs Best Available Therapy in GVHD: Clinical Trial page.